Alumnus Spotlight on Meet Vora
From Single Bench to Sensor Scale
GraphWear Technologies Inc. began its journey in 2015 at the University of Pennsylvania, founded by a group of graduate students determined to revolutionize healthcare through nanotechnology. Among them was Meet Vora, now Chief Operating Officer, whose expertise in sensor fabrication and nanotechnology has been instrumental in the company’s success. With a focus on needle-free, graphene-based sensors for continuous biomarker monitoring, GraphWear has made significant strides in advancing healthcare technology.
A key milestone in the company’s early years was its collaboration with the Philadelphia Eagles during the 2017-2018 NFL season. Using GraphWear’s novel graphene-based sensors to monitor glucose and lactate levels, the team measured player performance and recovery. Is it coincidence that the Eagles went on to win the Super Bowl that year? We don’t think so! The partnership with the Eagles was the first real-world demonstration of GraphWear’s technology potential and fueled the company’s drive to innovate further.
In 2017, GraphWear moved operations to San Francisco to join the MBC BioLabs community at the epicenter of tech and biotech. Working with limited resources—a single bench and half a hood—Meet and his team began hand-fabricating sensors in small batches. Reflecting on those early days, Meet shares, “Sensor fabrication is a multidisciplinary endeavor that demands precision engineering, innovative problem-solving, and adaptability, particularly when scaling from prototype development to large-scale production with limited resources.” This hands-on experience at MBC BioLabs became the foundation for scaling the company’s operations.
Today, GraphWear operates from an 11,000-square-foot facility, where sensor production has been scaled to meet growing demand. Meet’s leadership has been pivotal in navigating the complex challenges of scaling nanotechnology while ensuring the reliability and quality of the company’s graphene-based sensors. Alongside these efforts, Meet has contributed as a lead inventor on six patents, focusing on innovations such as graphene based field effect devices and scalable biosensor manufacturing methods.
GraphWear has raised $28 million in funding to date, enabling critical advancements in its technology and expanding its reach through clinical trials and strategic collaborations. As an MBC BioLabs alumnus, Meet’s story exemplifies the entrepreneurial spirit and dedication fostered by the MBC BioLabs community, reflecting how innovation can thrive from modest beginnings.
From its inception at Penn to its scaling success in a state-of-the-art facility, GraphWear’s journey is a testament to perseverance, creativity, and technical excellence. Meet Vora’s leadership continues to shape the company’s future, making a lasting mark on the field of non-invasive healthcare technology.